Skip to main content

Read the latest news about the use of biomarkers in research on Alzheimer's prevention.

16 Nov | 2022

The validity of nine biomarkers for diagnosing Alzheimer's disease in daily clinical practice has been determined

A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre and the University of Gothenburg has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres.

11 Aug | 2022

A new study identifies two biomarkers in the blood that better capture early signs of Alzheimer's

The study, which used data from almost 400 participants of the ALFA+ Study, determines that the biomarkers p-tau231 and p-tau217 measured in the blood are suitable for indicating brain changes related to the amyloid protein in people without cognitive symptoms.

23 Jul | 2021

The project on artificial intelligence algorithms in magnetic resonance obtains a 'Digital EIT 2021'

The organization under the European Commission will finance part of the project

04 Sep | 2020

Marc Suárez-Calvet is awarded an ERC Starting Grant to identify age-related blood factors as a therapeutic target for Alzheimer’s disease

The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor

07 Aug | 2020

BBRC presents more than 20 studies at the Alzheimer's Association International Conference 2020

The most prominent congress dedicated to Alzheimer's research has been held completely virtual

03 Aug | 2020

Proximity to parental age at onset of Alzheimer's indicates an increased risk of developing the disease in women

The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy

25 May | 2020

Air pollution causes damage to brain areas linked to Alzheimer's

BBRC researchers have detected that people most exposed to air pollution have greater brain atrophy and less cortical thickness in specific areas of the brain that are affected in Alzheimer's disease.

18 May | 2020

BBRC starts a new study on the relationship between insomnia and Alzheimer’s disease

Dr. Oriol Grau explains the goals of the study Alfa Sleep, which will start over the next months.

04 Mar | 2020

American philanthropists invest 2M euros to diagnose the early stages of Alzheimer’s disease through a blood test

The Alzheimer’s Drug Discovery Foundation funds the research, thanks to donations from Bill Gates, Jeff Bezos and several other philanthropists.